Literature DB >> 7249895

Beneficial effect of indomethacin on acid-induced esophagitis in cats.

G L Eastwood, B D Beck, D O Castell, F C Brown, J R Fletcher.   

Abstract

Acid-induced esophageal injury in the cat, produced by infusion of 0.1 N HCl (1 ml/min for 30 min) on 4 consecutive days, has been shown previously to adversely affect lower esophageal sphincter (LES) pressure. We studied the role of prostaglandins in acid-induced esophagitis and the associated LES hypotension by simultaneous treatment of some animals with indomethacin (150 micrograms/kg intravenous), a specific inhibitor of prostaglandin synthesis, either during production of esophagitis or during recovery. LES pressures and esophageal histology were compared to control groups which received acid alone. Indomethacin treatment resulted in more rapid healing of the esophageal inflammation and prevented or promptly corrected the esophagitis-associated LES hypotension. These studies provide further evidence that prostaglandins play an important role in the pathogenesis of acid-induced esophagitis and LES hypotension and raise the possibility that indomethacin, a prostaglandin synthetase inhibitor, may be of benefit in prevention or therapy of esophagitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249895     DOI: 10.1007/bf01367672

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Mucosal response to esophageal motor disorders.

Authors:  C E Pope
Journal:  Arch Intern Med       Date:  1976-05

2.  Indomethacin and canine lower esophageal sphincter pressure.

Authors:  R E Mokka; L Punto; M I Kairaluoma; T K Larmi
Journal:  Am J Gastroenterol       Date:  1977-04       Impact factor: 10.864

3.  Relation of esophageal reflux to lower esophageal sphincter pressures decreased by atropine.

Authors:  D B Skinner; T F Camp
Journal:  Gastroenterology       Date:  1968-04       Impact factor: 22.682

4.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

5.  Deleterious effects of prostaglandins on esophageal mucosa.

Authors:  R K Goyal
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

6.  Prostaglandins, aspirin-like drugs and analgesia.

Authors:  S H Ferreira
Journal:  Nat New Biol       Date:  1972-12-13

7.  Experimental esophagitis in cats impairs lower esophageal sphincter pressure.

Authors:  G L Eastwood; D O Castell; R H Higgs
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

8.  Response of the human cardia sphincter to circulating prostaglandins F2ALPHA and E2 and to antiinflammatory drugs.

Authors:  J B Dilawari; A Newman; J Poleo; J J Misiewicz
Journal:  Gut       Date:  1975-02       Impact factor: 23.059

9.  Mechanism of the lower esophageal sphincter relaxation. Action of prostaglandin E 1 and theophylline.

Authors:  R K Goyal; S Rattan
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

10.  Radiation esophagitis in the opossum: radioprotection with indomethacin.

Authors:  M G Northway; H I Libshitz; B M Osborne; M S Feldman; J J Mamel; J H West; I A Szwarc
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

View more
  13 in total

1.  Prostaglandin E2 is the major arachidonic acid metabolite secreted by esophageal mucosal cells in rabbits.

Authors:  P Jiménez; A Lanas; E Piazuelo; G Bioque; F Esteva
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

2.  Continuous versus intermittent acid exposure in production of esophagitis in feline model.

Authors:  K T Cassidy; K R Geisinger; B B Kraus; D O Castell
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

3.  Anti-inflammatory drugs and variceal bleeding: a case-control study.

Authors:  V De Lédinghen; D Heresbach; O Fourdan; P Bernard; M P Liebaert-Bories; J B Nousbaum; A Gourlaouen; M C Becker; D Ribard; P Ingrand; C Silvain; M Beauchant
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

4.  Acid-induced esophagitis in cats is prevented by sucralfate but not synthetic prostaglandin E.

Authors:  P O Katz; K R Geisinger; M Hassan; W C Wu; D Huang; D O Castell
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

5.  24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis.

Authors:  D A Lieberman
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

6.  Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.

Authors:  T Hayakawa; Y Fujiwara; M Hamaguchi; T Sugawa; M Okuyama; E Sasaki; T Watanabe; K Tominaga; N Oshitani; K Higuchi; T Arakawa
Journal:  Gut       Date:  2005-10-06       Impact factor: 23.059

Review 7.  Inflammatory mediators in the oesophagus.

Authors:  G P Morgan; J G Williams
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

8.  Oesophageal histology in long term users of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; S Dahill; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

9.  Effect of growth factors and prostaglandin E2 on restitution and proliferation of rabbit esophageal epithelial cells.

Authors:  P Jimenez; A Lanas; E Piazuelo; F Esteva
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

10.  Selective COX-2 inhibition is associated with decreased mucosal damage induced by acid and pepsin in rabbit esophagitis.

Authors:  Angel Lanas; Pilar Jiménez; Angel Ferrández; Alfredo Escartín; Juan Arenas; Francisco Esteva; Javier Ortego
Journal:  Inflammation       Date:  2003-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.